Skip to main content

Table 2 Treatment with Helixor® P and dose limiting toxicity (DLT)

From: Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer

Dose in mg

Number of patients

Treatment duration (weeks)

DLT

200

3

3

No

400

3

3

No

700

3

3

No

1200

3

3

No

2000

3

3

Yes (patient 15)

2000

3

3

No

2000

3

9

No